Latest Breaking News On - Zhiqiang shi - Page 1 : comparemela.com

Nicotine industry players pursue innovation to address smoking problem

Nicotine industry players have agreed to pursue innovation and new technologies to provide consumers with better and less harmful alternatives to combustible cigarettes. Mark Kehaya Scientific evidence concluded that it is the burning of tobacco that produces the thousands of disease- and deat

United statesNew zealandUnited kingdomMing dengThe philippinesMark kehayaPhilip morrisWilliam yuZhiqiang shiMeisen liuKevin pengGeorge cassels smithZinwi bioLisa smithTech coYunnan university

FEELM reinforces its commitment to innovations in atomization technology at 2021 UK Media Day

SMOORE, a global leader in offering vaping technology solutions, today announced that its flagship atomization tech brand, FEELM, hosts 2021 UK Media Day at .

United kingdomShi zhiqiangFrankie chenZhiqiang shiOur groupKingdom mediaKingdom media dayBusiness wireMedia dayChief scientistGlobal vape flavor map

SMOORE: FEELM Reinforces its Commitment to Innovations in Atomization Technology at 2021 UK Media Day

SMOORE: FEELM Reinforces its Commitment to Innovations in Atomization Technology at 2021 UK Media Day
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

United kingdomShi zhiqiangFrankie chenZhiqiang shiOur groupKingdom media dayMedia dayChief scientistBusiness wireGlobal vape flavor map

TodayIR: Smoore International Announces Two Year Extension of Agreement with AIM ImmunoTech to Develop and Test a New Inhalation Delivery Device for Ampligen

DJ EQS-News: Smoore International Announces Two Year Extension of Agreement with AIM ImmunoTech to Develop and Test a New Inhalation Delivery Device for Ampligen EQS-News / 28/05/2021 / 09:58 UTC+8

United statesZhiqiang shiShenzhen smoore technologyImmunotech incFinancial pressSmoore international holdingsResearch agreementSmoore international announces two year extensionNew inhalation delivery deviceInternational announces two year extensionAmpligen smoore international holdings limitedStock codeShenzhen smoore technology limitedMaterial transferChief scientistSmoore international holdings limited

AIM ImmunoTech Announces Two Year Extension of Agreement with Shenzhen Smoore Technology Limited to Develop and Test a New Inhalation Delivery Device for Ampligen

Home / Top News / AIM ImmunoTech Announces Two Year Extension of Agreement with Shenzhen Smoore Technology Limited to Develop and Test a New Inhalation Delivery Device for Ampligen AIM ImmunoTech Announces Two Year Extension of Agreement with Shenzhen Smoore Technology Limited to Develop and Test a New Inhalation Delivery Device for Ampligen Announces plans to conduct Phase 1/2 clinical study incorporating new inhalation technology if the preliminary results of the testing are positive OCALA, Fla., May 27, 2021 (GLOBE NEWSWIRE) AIM ImmunoTech Inc. (NYSE American: AIM) today announced that it has entered into a two-year extension of its Material Transfer and Research Agreement with Shenzhen Smoore Technology Limited (Smoore), a subsidiary of Smoore International Holdings Limited (HKEX: 6969), with the goal of developing Ampligen as a potential inhalation therapy for COVID-19 and potentially other respiratory viral diseases.

United statesThomask equelsZhiqiang shiSmoore international holdings limitedShenzhen smoore technology limitedImmunotech incCrescendo communicationsUtah state universityResearch agreementMaterial transferChief scientistPrivate securities litigation reform actஒன்றுபட்டது மாநிலங்களில்பிறை தகவல்தொடர்புகள்உட்டா நிலை பல்கலைக்கழகம்பொருள் பரிமாற்றம்